MemoryGel Silicone Gel-Filled Breast Implants
by Mentor Corp. United States PMA
PMA P030053 Product code FTR
Overview
The MemoryGel Silicone Gel-Filled Breast Implants are Prosthesis, Breast, Noninflatable, Internal, Silicone Gel-Filled, designed for breast augmentation and reconstruction. These devices are intended for women aged 22 or older for augmentation and for women of any age for reconstruction following tissue removal due to cancer, trauma, or congenital abnormalities. They may also be used in revision surgeries to correct or improve prior augmentation or reconstruction outcomes.
These implants are supplied sterile and are classified as Class III medical devices under FDA regulations. They are intended for surgical use only and must be implanted by qualified healthcare professionals in a controlled clinical setting. The devices are available in multiple sizes and are regulated under FDA_PMA authorization (PMA Number: P030053). Storage and handling must comply with sterile surgical protocols to ensure patient safety and device integrity.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP030053 | Date17 Nov 2006 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA PMA Active
Recalls
-
- Terminated Z-2326-2016
The box of 300cc MemoryGel Breast Implant was labeled with null manufacturing and expiration dates.
Specification
- Full name
- Mentor Memorygel Silicone Gel-Filled Breast Implants
- Trade Name
- Memorygel Silicone Gel -Filled Breast Implants
- Generic Name
- Prosthesis, breast, noninflatable, internal, silicone gel-filled
- PMA Number
- FDA Product Code
- FTR
- Device Class
- Class III
- Regulation
- 21 CFR Part 878.3540
- Advisory Committee
- General, Plastic Surgery
- FDA Decision
- APPR Approved
Other devices from Mentor Corp.
Questions
What are the primary uses for the MemoryGel Silicone Gel-Filled Breast Implants, and who qualifies for them?
The MemoryGel Silicone Gel-Filled Breast Implants are intended for **breast augmentation in women aged 22 or older** to increase breast size or correct/revise prior augmentation results. They are also approved for **breast reconstruction in women of any age** following tissue removal due to cancer, trauma, or congenital abnormalities, including revision surgeries to improve reconstruction outcomes. The device is not intended for cosmetic purposes in patients under 22.
Are these implants single-use or reusable, and how should they be stored?
The MemoryGel Silicone Gel-Filled Breast Implants are **sterile and intended for single-use only**. They must be stored according to sterile surgical protocols to maintain device integrity and patient safety. Improper storage could compromise sterility, so follow manufacturer guidelines for packaging and environmental conditions.
What regulatory pathway does this device follow, and how does that affect its availability?
This device follows the **FDA Pre-Market Approval (PMA) pathway**, authorized under PMA Number **P030053**. This means it has undergone rigorous clinical evaluation and approval before commercial distribution. Availability is restricted to **qualified healthcare professionals** in controlled surgical settings, as it is classified as a **Class III** device under FDA regulations.
Do these implants come in multiple sizes, and how would a clinician determine the appropriate size for a patient?
Yes, the MemoryGel Silicone Gel-Filled Breast Implants are available in **multiple sizes** (specific dimensions are listed in the FEI numbers provided). The appropriate size is determined by the surgeon based on patient anatomy, desired outcome, and clinical assessment—factors like breast tissue quality, patient body type, and aesthetic goals influence selection. Consult the manufacturer’s sizing guides for detailed reference.
Can these implants be used in revision surgeries, and if so, what scenarios are they approved for?
Yes, these implants are explicitly approved for **revision surgeries** to correct or improve outcomes of prior breast augmentation or reconstruction procedures. This includes addressing complications like capsular contracture, implant malposition, or patient dissatisfaction with initial results. The approval covers both **augmentation revisions** (for women ≥22) and **reconstruction revisions** (for any age).
Properties & raw data
Show properties, registry sources and raw records
Sources (1)
- FDA PMA P030053